LDN Video Interviews and Presentations

Dr Bob Lawrence, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Bob Lawrence shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Bob Lawrence from Wales was shocked when he first came across Low Dose Naltrexone (LDN), puzzled as to why such a simple treatment could be so effective at treating such devastating diseases.

He has found LDN to be very successful in his patients, some of whom have noticed improvements in their health within a matter of days.

He first prescribed LDN in 2000 and within weeks he had many of his patients on the drug. In this interview he explains LDN’s benefits and his shock as to why mainstream medicine is yet to adopt LDN as an integral component of treatment programs.

This is a summary of Dr Bob Lawrence’s interview. Please listen to the rest of Dr Lawrence’s interview  by clicking on the video above.

Laura - US: Cancer (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Laura from the US shares her story about her grade 4 Glioblastoma and Low Dose Naltrexone.  Laura first noticed symptoms with cognitive difficulty and then disorientation. The hospital diagnosed the grade 4 glioblastoma and told her she would die by November (the year before this interview). Laura went through the full cycles of radiotherapy and chemotherapy which of course made her situation worse. Laura’s daughter found out about Low Dose Naltrexone and suggested that as a possibility to help and they found a doctor who would prescribe it. Pretty quickly Laura regained some quality of life and now walks over a mile a day, which before was impossible.  Low Dose Naltrexone is not a cure but has given Laura some life back, she is convinced the tumour is shrinking.  Laura says the Low Dose Naltrexone is worth trying as it’s essentially side effect free and has prolonged her life with quality time.

Kimberly - US: Cancer, Fibromyalgia (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Kimberly, from the US takes LDN for fibromyalgia, and she also has a service dog (a cocker spaniel) who takes LDN for liver disease and liver cancer. 

She started her dog on the medication around a year ago, and noticed she could now walk, after spending a year without being able to do so, and is also surviving cancer and liver disease.

Kimberley has been ill with Fibromyalgia for around 17 years. Her symptoms were chronic fatigue at first, which eventually led to not being able to walk for three months after being incredibly active. 

Before taking LDN, Kimberly would spend the majority of her time housebound and depressed. She would also get mouth sores and a chronic cough along with a swollen face occasionally. Sometimes these symptoms lasting weeks upon weeks. Kimberly also mentions feeling pain as though someone has beaten her with a baseball bat. Exhaustion, lack of appetite, migraines and struggling to breathe also were felt regularly.

After taking LDN sourced from her own GP in California, she has felt more stable with an increased quality of life with no side effects.

Kimberly urges that people try the medication when asked if she recommends it saying “LDN can give them the quality of life.” She is very grateful for LDN, for herself and her service dog.

To view the entire interview, watch the video.

Any questions or comments you may have, please Contact Us. 

Kevin - England: Cancer (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Kevin from England, takes Low Dose Naltrexone (LDN) for Chronic Hepatitis, which then developed into Hepatocellular Carcinoma.

Kevin found LDN through a friend and his wife, who have been taking LDN for months, saying they are now symptom free. Due to LDN not being official within the NHS, Kevin managed to get some LDN privately. Now, two and a half years later, Kevin has had no further recurrences.

After Kevin had a liver transplant, he no longer takes LDN due to him being prescribed immunosuppressants. 

Although, Kevin does recommend Low Dose Naltrexone (LDN) to other people, his mother and friends. He also quotes that it probably did help save his life from his cancer journey.

This is a summary to listen to the entire interview by click the video link.

Jane - Scotland: Ovarian Cancer (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Jane from Edinburgh takes Low Dose Naltrexone (LDN) for ovarian cancer. 

Jane's stomach started to swell up, making her look 9 months pregnant in 10 days, she was admitted to hospital where she was told she had a bad diet, but after being readmitted the following week, they took 13 litres of fluid from her stomach, where scans then showed she had ovarian cancer. 

After 6 weeks she started chemotherapy, where she had a bad reaction to the initial dosages. After finishing chemo in July, she started taking Low Dose Naltrexone (LDN), at first she started to have disturbed nights, but now taking it in the morning, she had no bad effects, her mood has improved and will continue taking it where she will continue a follow up next year.

This is a summary to listen to the entire interview by click the video link.

Dr Wai Liu, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr. Wai Liu is from St. George’s Hospital in London UK. He had just published a paper on how low dose naltrexone (LDN) can affect certain cancer cell lines in the laboratory that hopefully will drive clinical trials, then get approval for LDN as a treatment for cancer.

They took cells from patients with certain forms of cancer and compared the effects on the gene expression profiles by LDN, and conventional-dose naltrexone. Genes involved in cell cycling, the way cancer cells can grow, can be controlled in the way they proliferate. They showed LDN could target certain genes responsible for the cell cycle, and if that was exploited, they might get a handle on how cancer would grow. Indeed, they showed LDN does slow the growth of certain cancer cells via its effect on these particular proteins. As well, they found that because of the effects on the cell cycle, LDN increased the proteins that controlled the ability of a cell to undergo cell death, and increase cell killing in those cancer cells.

Furthermore, after administering LDN for a few days followed by no LDN for a recovery phase, they found continued cell killing, something bizarre to them, but similar to what happens with other drugs such as cannabinoids, or a couple other agents. In certain situations they saw LDN as having no effect on cancer cells, but during the recovery phase, there was a much improved level of cell killing.

They also used different schedules of chemotherapy alongside LDN, like gemcitabine, oxaliplatin, and something else like cyclophosphamide, as they are proven cytotoxic agents. They showed on a laboratory petri dish level, that when using both LDN and a number of cytotoxic agents, there was a much-increased level of proteins such as BAX, that regulate the ability of a cancer cell to undergo cell death. Understanding the profile of how drugs work lets you predict the best drugs to combine with the drug you’re testing. So for example, using a form of chemotherapy that requires BAX to be present and LDN results in cooperation between two different drugs.

Dr. Liu is not aware of doctors using this information clinically. There are many anecdotal reports of how LDN can help alleviate cancer symptoms or help with cancer treatment. More research is needed to show the benefits of LDN in cancer patients, and in combination with various chemotherapies or immunotherapies. LDN does things to cancer cells, and people are beginning to see the value in LDN. The more people hear and read about LDN, and with an increasing amount of scientific literature to support LDN as a cancer therapy, the better chance to attract funding for clinical trials.

Summary from Dr. Wai Liu, listen to the video for the show.

Keywords: LDN, low dose naltrexone, cancer, chemotherapy, immunotherapy

Any questions or comments you may have, please contact us. I look forward to hearing from you. 

Dr Thomas Cowan, LDN Radio Show 14 Dec 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Thomas Cowan shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Thomas Cowan practices holistic medicine in San Francisco and prescribes Low Dose Naltrexone (LDN). He also has a new book called ‘Human Heart, Cosmic Heart’.

He first heard of LDN in 1992 from one of his patients with AIDS who requested it. This occurred again four years later, prompting Dr Cowan into researching LDN more thoroughly and learning about its many benefits in combating autoimmune diseases.

He says that LDN’s side effects are very uncommon and that in 95% of his autoimmune patients, he has prescribed LDN. Dr Cowan is a strong advocate of LDN.

This is a summary of Dr Thomas Cowan’s interview. Please listen to the rest of Dr Cowan’s interview by clicking on the video above.

Dr Thomas Cowan, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo

Dr Thomas Cowan shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Thomas Cowan first came across Low Dose Naltrexone (LDN) around 20 years ago when one of his close friends had incurable lymphoma. Having refused to continue on conventional treatment which had little to no effect on improving his health, he researched alternative treatments and came across LDN which drastically helped him to recover.

In the last decade of his career, Dr Cowan has predominantly treated patients with Ulcerative Colitis (UC) and Crohn’s Disease, finding that LDN can be successful in treating both diseases and providing great relief to his patients.

This is a summary of Dr Thomas Cowan’s interview. Please listen to the rest of Dr Cowan’s story by clicking on the video above.

Pharmacist Sahar Swidan, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Sahar Swidan shares her Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Sahar Swidan has had a busy career, traveling extensively to educate while running her own Compounding Pharmacy. She has witnessed many successes with the use of Low Dose Naltrexone (LDN) and also ultra-Low Dose Naltrexone. 

She is a humanitarian and is writing a book on opioid-free pain medicine in an effort to educate more people on the many other optional treatments. Many experts will add chapters.

In this interview she provides an interesting insight into pain management and how LDN can be used in its treatment.

This is a summary of Dr Sahar Swidan’s interview. Please listen to the rest of Dr Swidan’s story by clicking on the video above.

Dr Ronald Hoffman, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Ronald Hoffman shares his Low Dose Naltrexone (LDN) experience on ehe LDN Radio Show with Linda Elsegood.

Dr Ronald Hoffman is the founder and medical director of the Hoffman Center, New York’s oldest complementary medicine center. He's also the host of ‘Health Talk’, America's longest running physician-hosted radio program.

Dr Hoffman first came across Low Dose Naltrexone (LDN) in the 1980s when faced with a HIV patient. At the time there was no conventional treatment, but new approaches were emerging at the time in New York, headed by Dr Bernard Bihari.

One of such pioneering approaches was the use of LDN as a medication to treat drug addiction while also having a positive effect on the body’s immune response. Fascinated by Dr Bihari’s findings, Dr Hoffman has been a strong advocate of LDN since.

This is a summary of Dr Ronald Hoffman’s interview. Please listen to the rest of Dr Hoffman’s story by clicking on the video above.